nach oben

Archives of Gynecology and Obstetrics

Erschienen in:

06.06.2019 | Gynecologic Endocrinology and Reproductive Medicine

Quality of life among infertile PCOS patients

verfasst von: Pinar Angin, Tevfik Yoldemir, Kemal Atasayan

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Objective

To investigate whether quality of life differs between PCOS and non-PCOS infertile women.

Study design

Two questionnaire forms of quality of life (PCOSQ, SF-36) were given to 238 women. Patients were asked to answer all of the questions in both of the questionnaires. Of these 238 women, only 49 infertile PCOS patients, 47 infertile non-PCOS patients and 62 fertile PCOS patients fılled the forms completely.

Results

Both PCOSQ and SF-36 scores are lowest in infertile PCOS group. Although total PCOSQ score of infertile non-PCOS group was better than non-infertile PCOS and fertile PCOS groups; there was trend for lower scores when infertility is added on PCOS status.

Conclusion

The quality of life is lowest among infertile PCOS women. Both PCOS and infertility as individual factors may have negative impact in quality of life of reproductive age women.

Ramoglu S, Yoldemir T, Atasayan K, Yavuz DG (2017) Does cardiovascular risk vary according to the criteria for a diagnosis of polycystic ovary syndrome? J Obstet Gynaecol Res 43(12):1848–1854. https://doi.org/10.1111/jog.13455 CrossRefPubMed

Naughton MJ, McBee WL (1997) Health-related quality of life after hysterectomy. Clin Obstet Gynecol 40(4):947–957CrossRefPubMed

Colwell H, Mathias SD, Pasta DJ, Henning JM, Steege JF (1998) A health related quality of life instrument for symptomatic patients with endometriosis: a validation study. Am J Obstet Gynecol 179(1):47–55CrossRefPubMed

Dunaif A, Thomas A (2001) Current concepts in the polycystic ovary syndrome. Annu Rev Med 52:401–419CrossRefPubMed

Eggers S, Kirchengast S (2001) The polycystic ovary syndrome-a medical condition but also an important psychosocial problem. Coll Anthropol 25:673–685

Kitzinger C, Willmott J (2002) The thief of womanhood: women’s experience of polycystic ovarian syndrome. Soc Sci Med 54(3):349–361CrossRefPubMed

Ware JE, Snow KK, Kosinski M, Gandek B (1993) SF-36 health survey. Manual and interpretation guide. The Health Institute, Boston

Cronin L, Guyatt G, Grifth L, Wong E, Azziz R, Futterweit W, Cook D, Dunaif A (1998) Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab 83(6):1976–1987PubMed

Nygren KG, Sullivan E, Zegers-Hochschild F, Mansour R, Ishihara O, Adamson GD et al (2011) International Committee for Monitoring Assisted Reproductive Technology (ICMART) world report: assisted reproductive technology. Fertil Steril 95(7):2209–2222CrossRefPubMed

10.

Escobar-Morreale HF, Carmina E, Dewailly D et al (2012) Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update 18(2):146–170CrossRefPubMed

11.

Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19–25

12.

Gallagher D, Heymsfield SB, Heo M et al (2000) Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr 72:694–701CrossRefPubMed

13.

Mascarenhas MN, Flaxman SR, Boerma T, Vanderpoel S, Stevens GA (2012) National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys. PloS Med 9:e1001356CrossRefPubMedPubMedCentral

14.

Lujan ME, Chizen DR, Pierson RA (2008) Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies. J Obstet Gynaecol Can 30(8):671–679. https://doi.org/10.1016/S1701-2163(16)32915-2 CrossRefPubMedPubMedCentral

15.

Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2008) Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod 23:462–477CrossRef

16.

Moran LJ, Brinkworth G, Noakes M, Norman RJ (2006) Effects of lifestyle modification in polycystic ovarian syndrome. Reprod Biomed Online 12:569–578CrossRefPubMed

17.

Thomson RL, Buckley JD, Lim SS et al (2010) Lifestyle management improves quality of life and depression in overweight and obese women with polycystic ovary syndrome. Fertil Steril 94(5):1812–1816CrossRefPubMed

18.

Corte LD, La Rosa VL, Rapisarda AMC et al (2018) Current evidences and future perspectives on patient-oriented treatments for polycystic ovary syndrome: an overview. Ital J Gynaecol Obstet 30(1):7–20. https://doi.org/10.14660/2385-0868-81 CrossRef

19.

Chiofalo B, Laganà AS, Palmara V et al (2017) Fasting as possible complementary approach for polycystic ovary syndrome: hope or hype? Med Hypotheses 105:1–3CrossRefPubMed

20.

Valenti G, Rapisarda AMC, Vitale SG (2017) Evidence-based and patient-oriented inositol treatment in polycystic ovary syndrome: changing the perspective of the disease. Int J Endocrinol Metab 15(1):1–2 (e43695)

21.

Azziz R et al (2009) Task force on the phenotype of the polycystic ovary syndrome of the androgen excess and PCOS society. The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 91(2):456–488. https://doi.org/10.1016/j.fertnstert.2008.06.035 CrossRefPubMed

22.

Munoz ER, Sathyapalan T, Rossetti P et al (2018) Polycystic ovary syndrome: implication for drug metabolism on assisted reproductive techniques—a literature review. Adv Ther 35:1805–1815CrossRef

23.

Barnard L, Ferriday D, Guenther N, Strauss B, Balen AH, Dye L (2007) Quality of life and psychological wellbeing in polycystic ovary syndrome. Hum Reprod 22(8):2279–2286CrossRefPubMed

24.

Amiri FN, Tehrani FR, Simbar M, Montazeri A, Mohammad RA (2016) Health-related quality of life questionnaire for polycystic ovary syndrome (PCOSQ-50): development and psychometric properties pour. Qual Life Res 25:1791–1801CrossRef

25.

Van Wely M, Bayram N, Bossuyt PM, Van der Veen F (2004) Laparoscopic electrocautery of the ovaries versus recombinant FSH in clomiphene citrate-resistant polycystic ovary syndrome. Impact on women’s health-related quality of life. Hum Reprod 19:2244–2250CrossRefPubMed

26.

Coffey S, Bano G, Mason H (2006) Health-related quality of life in women with polycystic ovary syndrome: a comparison with the general population using the Polycystic Ovary Syndrome Questionnaire (PCOSQ) and the Short Form-36 (SF-36). Gynecol Endocrinol 22(2):80–86CrossRefPubMed

27.

Li Y, Li Y, Ng EHY, Victorin ES, Hou L, Wu T, Han F, Wu X (2011) Polycystic ovary syndrome is associated with negatively variable impacts on domains of health-related quality of life: evidence from a meta-analysis. Fertil Steril 96(2):452–458CrossRefPubMed

28.

Chachamovich JR, Chachamovich E, Ezer H, Fleck MP, Knauth D, Passos EP (2010) Investigating quality of life and health-related quality of life in infertility: a systematic review. J Psychosom Obstet Gynecol 31(2):101–110CrossRef

29.

Vitale SG, La Rosa VL, Rapisarda AM, Laganà AS (2017) Psychology of infertility and assisted reproductive treatment: the Italian situation. J Psychosom Obstet Gynaecol 38(1):1–3. https://doi.org/10.1080/0167482X.2016.1244184 CrossRefPubMed

30.

Jones GL, Benes K, Clark TL, Denham R, Holder MG, Haynes TJ et al (2004) The Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire (PCOSQ): a validation. Hum Reprod 19(2):371–377CrossRefPubMed

31.

McCook JG, Reame NE, Thatcher SS (2005) Health-related quality of life issues in women with polycystic ovary syndrome. J Obstet Gynecol Neonatal Nurs 34:12–20CrossRefPubMed

32.

Hashimoto DM, Schmid J, Martins FM, Fonseca AM, Andrade LHB, Kirchengast S, Eggers S (2003) The impact of the weight status on subjective symptomatology of the polycystic ovaries syndrome: a crosscultural comparison between Brazilian and Austrian women. Anthropol Anz 61:297–310PubMed

33.

Schmid J, Kirchengast S, Binstorfer EV, Huber J (2004) Infertility caused by PCOS—health-related quality of life among Austrian and Moslem immigrant women in Austria. Hum Reprod 19(10):2251–2257CrossRefPubMed

34.

Ching HL et al (2007) Quality of life and psychological morbidity in women with polycystic ovary syndrome: body mass index, age and the provision of patient information are significant modifiers. Clin Endocrinol 66:373–379CrossRef

Titel: Quality of life among infertile PCOS patients
verfasst von: Pinar Angin
Tevfik Yoldemir
Kemal Atasayan
Publikationsdatum: 06.06.2019
Verlag: Springer Berlin Heidelberg
Erschienen in: Archives of Gynecology and Obstetrics / Ausgabe 2/2019
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-019-05202-z

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Internistische Arzneimitteltherapie Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Quality of life among infertile PCOS patients

Abstract

Objective

Study design

Results

Conclusion

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

Fehlerkultur in der Medizin – Offenheit zählt!

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

Update Gynäkologie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Objective

Study design

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2019

Isolated bladder exstrophy in prenatal diagnosis

Type-II endometrial cancer: role of adipokines

Impact of gene polymorphisms on the systemic toxicity to paclitaxel/carboplatin chemotherapy for treatment of gynecologic cancers

Letter to the editor

Association of trimester-specific gestational weight gain with birth weight and fetal growth in a large community-based population

Therapy of isolated locoregional recurrent carcinoma of the breast

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

Fehlerkultur in der Medizin – Offenheit zählt!

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

Update Gynäkologie